Results 111 to 120 of about 225,005 (265)

Current evidence and insights on single vs. double dose of basiliximab in adult solid organ transplant recipients: A systematic review

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this systematic review was to assess all available clinical data regarding the use of a single dose of basiliximab in solid organ transplantation compared to the standard double dosage, with particular interest in efficacy, safety and cost‐savings.
Alessio Provenzani, Braidon A. Lape, Anneliese M. Harp, Victoria Weisbrod, Lavinia Piazza   +4 more
wiley   +1 more source

Efficacy and safety of empagliflozin for treating neutropenia and neutrophil dysfunction in paediatric patients with glycogen storage disease type Ib: A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims Glycogen storage disease type Ib (GSD‐Ib) is a rare genetic disorder causing neutropenia and neutrophil dysfunction in children. G‐CSF has been the primary treatment, but emerging data support the potential of empagliflozin, an SGLT2 inhibitor, as a promising investigational option.
Elizabeth Iwasyk, Ryan Jin, Fabio Tuzzolino, Giusy Ranucci, Donatella Madonia, Alessio Provenzani   +5 more
wiley   +1 more source

Antileukemic therapies for older adults with AML ineligible for conventional therapy: systematic review and meta-analysis. [PDF]

Blood Adv
Oliveros MJ, Chowdhury SR, Roldan Y, Ibrahim S, Bravo-Soto G, Foucar CE, Bhogal G, Burgos-Mansilla B, Bagherianlemraski M, Movahed H, Gutierrez-Arias R, Khorrami Taj T, Chang Y, Hadeiy SK, Couban R, Demichelis-Gomez R, Malcovati L, Loh KP, Platzbecker U, Gilberto L, Treitz J, Baer MR, Marini BL, Mattison R, Sekeres MA, Brignardello-Petersen R.   +25 more
europepmc   +1 more source

Pentoxifylline dose finding trial in preterm neonates with suspected late onset sepsis (PTX‐trial)

British Journal of Clinical Pharmacology, EarlyView.
Aim The aim of this study (PTX‐trial) is to determine the optimal dose of pentoxifylline (PTX) in preterm neonates (gestational age < 30 weeks) with (suspected) late onset sepsis (LONS). Methods The PTX‐trial is a prospective multicentre open‐label sequential dose‐optimization study with an adapted continual reassessment method.
Serife Kurul, H. Rob Taal, Jan Mazela, Ryszard Lauterbach, Irwin K. M. Reiss, Karel Allegaert, Robert B. Flint, Sinno H. P. Simons   +7 more
wiley   +1 more source

Mentalizing on the edge: borderline traits and their association with real-time self-reflection - an ecological momentary assessment study. [PDF]

Borderline Personal Disord Emot Dysregul
Höller I, Schwitzky S, Forkmann T, Forster S, Santangelo PS.   +4 more
europepmc   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

Safety and efficacy of advanced combination therapies for treating inflammatory bowel disease in adults: a systematic review and meta-analysis. [PDF]

BMJ Open Gastroenterol
Radford S, Albuquerque DAN, Najeeb Z, Agarwal D, John A, Gordon M, Sinopoulou V, Moran G.   +7 more
europepmc   +1 more source

Language of certainty [PDF]

American Journal of Roentgenology, 1986
openaire   +2 more sources

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

British Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Clinical characteristics of patients presenting with depressive states who are not receiving antidepressants: A multicenter observational study in Japanese psychiatric practice. [PDF]

PCN Rep
Muraoka H, Hashimoto R, Fukumoto K, Kodaka F, Ohi K, Inada K, Yasui-Furukori N.   +6 more
europepmc   +1 more source